Joint Venture26 Jul 2025, 03:44 pm
Shukra Pharmaceuticals Ltd. Executes Agreement with APITCO Limited for Healthcare Government Assignments
AI Summary
Shukra Pharmaceuticals Ltd. has executed an agreement with APITCO Limited on 25th July 2025. The purpose of this agreement is to collaborate on various healthcare government assignments across sectors, leveraging APITCO's expertise as a PSU and Shukra's capabilities in healthcare project management, services, and training. This collaboration aims to contribute to national-level developmental, industrial, and consulting initiatives. All projects undertaken through this collaboration will be executed under defined Service Level Agreements (SLAs) with detailed scope, timelines, deliverables, and performance standards.
Key Highlights
- Execution of an Agreement between Shukra Pharmaceuticals Ltd. and APITCO Limited on 25th July 2025
- Collaboration on various healthcare government assignments across sectors
- Leveraging APITCO's expertise as a PSU and Shukra's capabilities in healthcare project management, services, and training
- Projects to be executed under defined Service Level Agreements (SLAs)
- No shareholding between the two companies